The global Hospital Injectable Drugs market size was valued at US$ 39530 million in 2023. With growing demand in downstream market, the Hospital Injectable Drugs is forecast to a readjusted size of US$ 55550 million by 2030 with a CAGR of 5.0% during review period.
The research report highlights the growth potential of the global Hospital Injectable Drugs market. Hospital Injectable Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Hospital Injectable Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Hospital Injectable Drugs market.
Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. In tablet form, some of the drugs become ineffective as they get dismantled in the stomach owing to the digestive enzymes. Generic injectables are pharmaceutical drugs that are bio-equivalent of a branded injectable in terms of dosage, strength, performance, intended use, side-effects and route of administration.
In 2019, North America held the main share in global hospital injectable drugs market,with the propotion of 35%,Europe followed loosely ,at the propotion of 33%.
Hospira (Pfizer Inc.) occupied the biggest global hospital injectable drugs market share(13%), Fresenius Kabi followed closely at the propotion of 13%, Baxter and Sichuan Kelun Pharmaceutical also played a virtal role in the market.
Key Features:
The report on Hospital Injectable Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Hospital Injectable Drugs market. It may include historical data, market segmentation by Type (e.g., Generic Sterile Injectables, Sterile Intravenous (IV) Solutions), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Hospital Injectable Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Hospital Injectable Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Hospital Injectable Drugs industry. This include advancements in Hospital Injectable Drugs technology, Hospital Injectable Drugs new entrants, Hospital Injectable Drugs new investment, and other innovations that are shaping the future of Hospital Injectable Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Hospital Injectable Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Hospital Injectable Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Hospital Injectable Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Hospital Injectable Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Hospital Injectable Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Hospital Injectable Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Hospital Injectable Drugs market.
Market Segmentation:
Hospital Injectable Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Generic Sterile Injectables
Sterile Intravenous (IV) Solutions
Segmentation by application
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Hospira (Pfizer Inc.)
Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hospital Injectable Drugs Market Size 2019-2030
2.1.2 Hospital Injectable Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Hospital Injectable Drugs Segment by Type
2.2.1 Generic Sterile Injectables
2.2.2 Sterile Intravenous (IV) Solutions
2.3 Hospital Injectable Drugs Market Size by Type
2.3.1 Hospital Injectable Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Hospital Injectable Drugs Market Size Market Share by Type (2019-2024)
2.4 Hospital Injectable Drugs Segment by Application
2.4.1 Oncology
2.4.2 Anesthesia
2.4.3 Anti-Infectives
2.4.4 Parenteral Nutrition
2.4.5 Cardiovascular Diseases
2.5 Hospital Injectable Drugs Market Size by Application
2.5.1 Hospital Injectable Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Hospital Injectable Drugs Market Size Market Share by Application (2019-2024)
3 Hospital Injectable Drugs Market Size by Player
3.1 Hospital Injectable Drugs Market Size Market Share by Players
3.1.1 Global Hospital Injectable Drugs Revenue by Players (2019-2024)
3.1.2 Global Hospital Injectable Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Hospital Injectable Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Hospital Injectable Drugs by Regions
4.1 Hospital Injectable Drugs Market Size by Regions (2019-2024)
4.2 Americas Hospital Injectable Drugs Market Size Growth (2019-2024)
4.3 APAC Hospital Injectable Drugs Market Size Growth (2019-2024)
4.4 Europe Hospital Injectable Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Hospital Injectable Drugs Market Size Growth (2019-2024)
5 Americas
5.1 Americas Hospital Injectable Drugs Market Size by Country (2019-2024)
5.2 Americas Hospital Injectable Drugs Market Size by Type (2019-2024)
5.3 Americas Hospital Injectable Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hospital Injectable Drugs Market Size by Region (2019-2024)
6.2 APAC Hospital Injectable Drugs Market Size by Type (2019-2024)
6.3 APAC Hospital Injectable Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Hospital Injectable Drugs by Country (2019-2024)
7.2 Europe Hospital Injectable Drugs Market Size by Type (2019-2024)
7.3 Europe Hospital Injectable Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hospital Injectable Drugs by Region (2019-2024)
8.2 Middle East & Africa Hospital Injectable Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Hospital Injectable Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Hospital Injectable Drugs Market Forecast
10.1 Global Hospital Injectable Drugs Forecast by Regions (2025-2030)
10.1.1 Global Hospital Injectable Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Hospital Injectable Drugs Forecast
10.1.3 APAC Hospital Injectable Drugs Forecast
10.1.4 Europe Hospital Injectable Drugs Forecast
10.1.5 Middle East & Africa Hospital Injectable Drugs Forecast
10.2 Americas Hospital Injectable Drugs Forecast by Country (2025-2030)
10.2.1 United States Hospital Injectable Drugs Market Forecast
10.2.2 Canada Hospital Injectable Drugs Market Forecast
10.2.3 Mexico Hospital Injectable Drugs Market Forecast
10.2.4 Brazil Hospital Injectable Drugs Market Forecast
10.3 APAC Hospital Injectable Drugs Forecast by Region (2025-2030)
10.3.1 China Hospital Injectable Drugs Market Forecast
10.3.2 Japan Hospital Injectable Drugs Market Forecast
10.3.3 Korea Hospital Injectable Drugs Market Forecast
10.3.4 Southeast Asia Hospital Injectable Drugs Market Forecast
10.3.5 India Hospital Injectable Drugs Market Forecast
10.3.6 Australia Hospital Injectable Drugs Market Forecast
10.4 Europe Hospital Injectable Drugs Forecast by Country (2025-2030)
10.4.1 Germany Hospital Injectable Drugs Market Forecast
10.4.2 France Hospital Injectable Drugs Market Forecast
10.4.3 UK Hospital Injectable Drugs Market Forecast
10.4.4 Italy Hospital Injectable Drugs Market Forecast
10.4.5 Russia Hospital Injectable Drugs Market Forecast
10.5 Middle East & Africa Hospital Injectable Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Hospital Injectable Drugs Market Forecast
10.5.2 South Africa Hospital Injectable Drugs Market Forecast
10.5.3 Israel Hospital Injectable Drugs Market Forecast
10.5.4 Turkey Hospital Injectable Drugs Market Forecast
10.5.5 GCC Countries Hospital Injectable Drugs Market Forecast
10.6 Global Hospital Injectable Drugs Forecast by Type (2025-2030)
10.7 Global Hospital Injectable Drugs Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Hospira (Pfizer Inc.)
11.1.1 Hospira (Pfizer Inc.) Company Information
11.1.2 Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Offered
11.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Hospira (Pfizer Inc.) Main Business Overview
11.1.5 Hospira (Pfizer Inc.) Latest Developments
11.2 Baxter
11.2.1 Baxter Company Information
11.2.2 Baxter Hospital Injectable Drugs Product Offered
11.2.3 Baxter Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Baxter Main Business Overview
11.2.5 Baxter Latest Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Information
11.3.2 Fresenius Kabi Hospital Injectable Drugs Product Offered
11.3.3 Fresenius Kabi Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Fresenius Kabi Main Business Overview
11.3.5 Fresenius Kabi Latest Developments
11.4 Sandoz (Novartis)
11.4.1 Sandoz (Novartis) Company Information
11.4.2 Sandoz (Novartis) Hospital Injectable Drugs Product Offered
11.4.3 Sandoz (Novartis) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sandoz (Novartis) Main Business Overview
11.4.5 Sandoz (Novartis) Latest Developments
11.5 Hikma Pharmaceuticals PLC
11.5.1 Hikma Pharmaceuticals PLC Company Information
11.5.2 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Offered
11.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Hikma Pharmaceuticals PLC Main Business Overview
11.5.5 Hikma Pharmaceuticals PLC Latest Developments
11.6 Dr. Reddy’s Laboratories Ltd
11.6.1 Dr. Reddy’s Laboratories Ltd Company Information
11.6.2 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product Offered
11.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Dr. Reddy’s Laboratories Ltd Main Business Overview
11.6.5 Dr. Reddy’s Laboratories Ltd Latest Developments
11.7 Grifols
11.7.1 Grifols Company Information
11.7.2 Grifols Hospital Injectable Drugs Product Offered
11.7.3 Grifols Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Grifols Main Business Overview
11.7.5 Grifols Latest Developments
11.8 Nichi-Iko Group (Sagent)
11.8.1 Nichi-Iko Group (Sagent) Company Information
11.8.2 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Offered
11.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Nichi-Iko Group (Sagent) Main Business Overview
11.8.5 Nichi-Iko Group (Sagent) Latest Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Information
11.9.2 Teva Pharmaceutical Hospital Injectable Drugs Product Offered
11.9.3 Teva Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Teva Pharmaceutical Main Business Overview
11.9.5 Teva Pharmaceutical Latest Developments
11.10 Otsuka
11.10.1 Otsuka Company Information
11.10.2 Otsuka Hospital Injectable Drugs Product Offered
11.10.3 Otsuka Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Otsuka Main Business Overview
11.10.5 Otsuka Latest Developments
11.11 B.Braun
11.11.1 B.Braun Company Information
11.11.2 B.Braun Hospital Injectable Drugs Product Offered
11.11.3 B.Braun Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 B.Braun Main Business Overview
11.11.5 B.Braun Latest Developments
11.12 JW Life Science
11.12.1 JW Life Science Company Information
11.12.2 JW Life Science Hospital Injectable Drugs Product Offered
11.12.3 JW Life Science Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 JW Life Science Main Business Overview
11.12.5 JW Life Science Latest Developments
11.13 Auromedics
11.13.1 Auromedics Company Information
11.13.2 Auromedics Hospital Injectable Drugs Product Offered
11.13.3 Auromedics Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Auromedics Main Business Overview
11.13.5 Auromedics Latest Developments
11.14 Sanofi
11.14.1 Sanofi Company Information
11.14.2 Sanofi Hospital Injectable Drugs Product Offered
11.14.3 Sanofi Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Sanofi Main Business Overview
11.14.5 Sanofi Latest Developments
11.15 Gland Pharma
11.15.1 Gland Pharma Company Information
11.15.2 Gland Pharma Hospital Injectable Drugs Product Offered
11.15.3 Gland Pharma Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Gland Pharma Main Business Overview
11.15.5 Gland Pharma Latest Developments
11.16 Endo International PLC
11.16.1 Endo International PLC Company Information
11.16.2 Endo International PLC Hospital Injectable Drugs Product Offered
11.16.3 Endo International PLC Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Endo International PLC Main Business Overview
11.16.5 Endo International PLC Latest Developments
11.17 Sichuan Kelun Pharmaceutical
11.17.1 Sichuan Kelun Pharmaceutical Company Information
11.17.2 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Offered
11.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Sichuan Kelun Pharmaceutical Main Business Overview
11.17.5 Sichuan Kelun Pharmaceutical Latest Developments
11.18 Cisen Pharmaceutical
11.18.1 Cisen Pharmaceutical Company Information
11.18.2 Cisen Pharmaceutical Hospital Injectable Drugs Product Offered
11.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Cisen Pharmaceutical Main Business Overview
11.18.5 Cisen Pharmaceutical Latest Developments
11.19 Shijiazhuang No. 4 Pharmaceutical
11.19.1 Shijiazhuang No. 4 Pharmaceutical Company Information
11.19.2 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Offered
11.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Shijiazhuang No. 4 Pharmaceutical Main Business Overview
11.19.5 Shijiazhuang No. 4 Pharmaceutical Latest Developments
11.20 Shandong Hualu Pharmaceutical
11.20.1 Shandong Hualu Pharmaceutical Company Information
11.20.2 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Offered
11.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Shandong Hualu Pharmaceutical Main Business Overview
11.20.5 Shandong Hualu Pharmaceutical Latest Developments
11.21 CR Double-Crane
11.21.1 CR Double-Crane Company Information
11.21.2 CR Double-Crane Hospital Injectable Drugs Product Offered
11.21.3 CR Double-Crane Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 CR Double-Crane Main Business Overview
11.21.5 CR Double-Crane Latest Developments
12 Research Findings and Conclusion
*If Applicable.